Table 1 Baseline Characterisitics of the study population.
From: Supportive treatment of vascular dysfunction in pediatric subjects with obesity: the OBELIX study
N | % | |
---|---|---|
Patients enrolled | 48 | |
Drop-outs | 21 | 43.75 |
Age (years) | 12.85 ± 3.04 | |
Gender (male) | 25 | 52.08 |
Weight (kg) | 76.90 | [66.0–92.5] |
BMI | 30.89 ± 5.22 | |
BMI Z-score | 0.61 | [0.22–1.12] |
Ethnicity | ||
Caucasic | 41 | 85.42 |
North African | 4 | 8.33 |
Moroccan | 3 | 6.25 |
Sport | ||
Sport type scorea | 3 | [2–3] |
hours/week | 3 | [1–4] |
Dietary fat intake | ||
Low | 23 | 47.92 |
Medium | 23 | 47.92 |
High | 2 | 4.17 |
Drugs | ||
d-Vitamin | 8 | 16.67 |
Methylphenidate | 1 | 2.08 |
Montelukast | 1 | 2.08 |
None | 38 | 79.17 |